-
Impact of New Cervical Cancer Screening Program Using Human Papillomavirus (HPV) Deoxyribonucleic Acid (DNA) Testing on Urban-Rural Disparities in Thailand: A Post-Hoc Distributional Cost-Effectiveness Analysis
Mar 10, 2025, 14:00 PM -
Real-World Health-Related Quality of Life and Treatment Satisfaction in Patients With High-Risk Non-Muscle Invasive Bladder Cancer
Mar 10, 2025, 14:00 PM -
Comparison of Machine Learning Models To Predict US Adolescent Mentalhealth Trends
Mar 10, 2025, 14:00 PM -
The Impact of the Inflation Reduction Act on Rare Diseases and Orphan Drugs
Mar 10, 2025, 14:00 PM -
Analysis of Antibody-Drug Conjugate Usage in Patients Undergoing Circulating Tumor DNA Testing
Mar 10, 2025, 14:00 PM -
Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research
Mar 10, 2025, 14:00 PM -
Optimizing Communication Strategies for COPD Management: Effectiveness of Educational Video and Pamphlet Interventions
Mar 10, 2025, 14:00 PM -
Current Evidence and Research Gaps on the Economic Burden of Graves' Disease: A Targeted Literature Review
Mar 10, 2025, 14:00 PM -
Redesigning the Care Process to Improve the Experience of Patients with Multiple Sclerosis Throughout the Patient Journey. EMpodera
Mar 10, 2025, 14:00 PM -
Considerations for Health Economic Modeling in Phenylketonuria (PKU): Insights From a Modified Delphi Panel
Mar 10, 2025, 14:00 PM -
Does Our Instrument Include the Right Response Options? Empirical Evidence to Evaluate Floor and Ceiling Effects for Multi-Item Ordinal Instruments
Mar 10, 2025, 14:00 PM -
Epidemiology, Healthcare Resource Utilization, and Costs of Unresectable Locally Advanced or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma in China
Mar 10, 2025, 14:00 PM -
Predicted Lifetime Health Care Resource Use Costs Associated With The Treatment Of Patients With Primary Biliary Cholangitis From A UK Payer Perspective
Mar 10, 2025, 14:00 PM -
Moving Beyond Partitioned Survival Models in Oncology Submissions: Incorporation of Canada's Drug Agency Guidance on Model Structure
Mar 10, 2025, 14:00 PM -
Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling
Mar 10, 2025, 14:00 PM -
Precision Medicine Enabled Benefits Management for Oral Diabetes and Weight Loss Management
Mar 10, 2025, 14:00 PM -
Estimating the U.S. Economic Burden of Autoimmune Diseases: A Pilot Systematic Literature Review
Mar 10, 2025, 14:00 PM -
Payer Archetypes and Decision-Making in the United States (US): A framework for Generalised Cost-Effectiveness Analysis (GCEA) Value Elements to Optimize Patient Access and Equity
Mar 10, 2025, 14:00 PM -
Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States.
Mar 10, 2025, 14:00 PM -
Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities
Mar 10, 2025, 14:00 PM
